PARP inhibitors induce a senescence phenotype in non‐small cell lung carcinoma cell lines
Talazoparib is the most potent inducer of senescence among different PARP1 inhibitors in human NSCLC cells. In the absence of PARP, no senescence phenotype was observed, demonstrating that PARP1 is necessary for the induction of senescence by this inhibitor.
Camille Huart +7 more
wiley +1 more source
Chemical Protein Engineering: Backbone Cyclization Rescues Folding of a 183-Residue Truncated Domain of Malaria Parasite Protein PfAMA1. [PDF]
Mannuthodikayil J +4 more
europepmc +1 more source
Erythropoietin administration suppresses hepatic soluble epoxide hydrolase (sEH) expression, leading to increased CYP‐derived epoxides. This is associated with a shift in hepatic macrophage polarization characterized by reduced M1 markers and increased M2 markers, along with reduced hepatic inflammation, suppressed hepatic lipogenesis, and attenuated ...
Takeshi Goda +12 more
wiley +1 more source
Beyond small molecules: advancing MYC-targeted cancer therapies through protein engineering. [PDF]
Edaibis R, Akel R, Shin JA.
europepmc +1 more source
A systematic analysis of regression models for protein engineering. [PDF]
Michael R +7 more
europepmc +1 more source
Metabolic reprogramming and computation-aided protein engineering for high-level de novo biosynthesis for 2-phenylethanol in <i>Pichia pastoris</i>. [PDF]
Sun L +7 more
europepmc +1 more source
The Protein Engineering of Zearalenone Hydrolase Results in a Shift in the pH Optimum of the Relative Activity of the Enzyme. [PDF]
Dotsenko A +5 more
europepmc +1 more source
New advances in protein engineering for industrial applications: Key takeaways. [PDF]
Ndochinwa GO +7 more
europepmc +1 more source
Improving Downstream Process Related Manufacturability Based on Protein Engineering-A Feasibility Study. [PDF]
Capito F +7 more
europepmc +1 more source

